Delivery Order SPE2DB20D3303-SPE2DB23FZ8F8
Award Date 6/22/23
Potential Completion Date 6/23/23
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,483.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENBREL 50 MG/ML syringes. As the prime contractor, Amerisourcebergen will deliver the medication to a location in Conshohocken, Pennsylvania by July 20, 2023 to support the Department of Defense's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime without involvement of major...
- The Defense Logistics Agency awarded a $48,643.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4562194108 ENBREL 50 MG/ML SYRINGEML. The contract will be performed in Conshohocken, Pennsylvania over a three day period concluding on September 18, 2023. As a pharmaceutical distributor, Amerisourcebergen will supply the auto-injector medication to the DLA, the logistics combat support agency of the United States Department of Defense, in support of...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of ENBREL 25 mg/0.5 ml syringes. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $38,320 delivery order to Amerisourcebergen Drug Corporation for ENBREL 50 MG/ML syringes. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a firm fixed-price contract running from July 7-10, 2023. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set-asides were specified. The delivery order was issued against an existing DLA-wide vehicle,...
- The Defense Logistics Agency Troop Support Medical awarded a $19,816 delivery order to Amerisourcebergen Drug Corporation for ENBREL 50 MG/ML syringes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to an unknown customer by June 28, 2023 under firm fixed pricing. No additional details were provided regarding subcontractors or the Defense Logistics Agency's programs. The delivery order was issued against an...
- The Defense Logistics Agency awarded a $34,953.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pharmaceutical supply. The contract, executed on September 17, 2025, represents a non-competitive delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $10,359.88 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml syringes, with an ultimate completion date of September 16, 2025. The contract was competitively awarded with no set-aside designation and is structured as a firm fixed-price delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $10,429 delivery order to Amerisourcebergen Drug Corporation for ENBREL 50 MG/ML syringes. The firm fixed price order calls for delivery to a facility in Conshohocken, Pennsylvania by August 28, 2023. DLA utilizes such contracts to procure pharmaceutical products in support of U.S. military treatment facilities and beneficiaries. As a top 10 prime contractor for DLA, Amerisourcebergen will likely fulfill this order from existing pharmaceutical inventories...
- The Defense Logistics Agency awarded a $72,895.88 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL syringes, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for ENBREL 50 mg/ml syringes valued at $29,284.84. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania facility with...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB23FZ8F8Delivery Order
The Defense Logistics Agency awarded a $10,719.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENBREL 50 MG/ML syringes to be delivered to a facility in Conshohocken, Pennsylvania by June 23, 2023. As a major pharmaceutical distributor, Amerisourcebergen will supply the auto-injector medication to support the Department of Defense's medical readiness and treatment programs. No subcontractors or additional context were provided regarding this small, short-term order under an existing DLA pharmaceuticals contract vehicle.
Generated 12/19/23, 1:33 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 6/22/23 |